1oqa: Difference between revisions

New page: left|200px<br /> <applet load="1oqa" size="450" color="white" frame="true" align="right" spinBox="true" caption="1oqa" /> '''Solution structure of the BRCT-c domain fro...
 
No edit summary
Line 1: Line 1:
[[Image:1oqa.gif|left|200px]]<br />
[[Image:1oqa.gif|left|200px]]<br /><applet load="1oqa" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1oqa" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1oqa" />
caption="1oqa" />
'''Solution structure of the BRCT-c domain from human BRCA1'''<br />
'''Solution structure of the BRCT-c domain from human BRCA1'''<br />


==Overview==
==Overview==
BRCA1 is a tumor suppressor protein associated with breast and ovarian, cancer. The C-terminal region of BRCA1 consists of two closely spaced BRCT, domains which mediate essential biological functions, including regulation, of transcription and control of cell-cycle progression by their, interaction with phosphorylated effector proteins. Here we report the NMR, structure of the isolated C-terminal BRCT domain (BRCT-c) from human, BRCA1. BRCT-c is well-structured in solution, folding independently in the, absence of its BRCT-n counterpart. Ultracentrifugation experiments and, size exclusion chromatography reveal that BRCT-c exists as a monomer under, near-physiological conditions. Dynamics measurements from NMR data show, three loops which coincide with the most variable sequence regions in BRCT, domains, to be genuinely flexible in solution. The solution structure of, BRCT-c shows subtle conformational changes when compared to the crystal, structure of BRCT-c in the tandem repeat of BRCA1. These affect sites, involved in formation of the BRCT-n-BRCT-c interface and the binding to, phosphoserine-containing peptides. The results suggest that the presence, of native BRCT-n and a properly aligned BRCT-n-BRCT-c interface are, essential if BRCT-c is to adopt a biologically active conformation., Structural consequences of cancer-associated mutations and biological, implications of the dynamic behavior are discussed.
BRCA1 is a tumor suppressor protein associated with breast and ovarian cancer. The C-terminal region of BRCA1 consists of two closely spaced BRCT domains which mediate essential biological functions, including regulation of transcription and control of cell-cycle progression by their interaction with phosphorylated effector proteins. Here we report the NMR structure of the isolated C-terminal BRCT domain (BRCT-c) from human BRCA1. BRCT-c is well-structured in solution, folding independently in the absence of its BRCT-n counterpart. Ultracentrifugation experiments and size exclusion chromatography reveal that BRCT-c exists as a monomer under near-physiological conditions. Dynamics measurements from NMR data show three loops which coincide with the most variable sequence regions in BRCT domains, to be genuinely flexible in solution. The solution structure of BRCT-c shows subtle conformational changes when compared to the crystal structure of BRCT-c in the tandem repeat of BRCA1. These affect sites involved in formation of the BRCT-n-BRCT-c interface and the binding to phosphoserine-containing peptides. The results suggest that the presence of native BRCT-n and a properly aligned BRCT-n-BRCT-c interface are essential if BRCT-c is to adopt a biologically active conformation. Structural consequences of cancer-associated mutations and biological implications of the dynamic behavior are discussed.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1OQA is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1OQA OCA].  
1OQA is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1OQA OCA].  


==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Ball, L.J.]]
[[Category: Ball, L J.]]
[[Category: Gaiser, O.J.]]
[[Category: Gaiser, O J.]]
[[Category: Heinemann, U.]]
[[Category: Heinemann, U.]]
[[Category: Kuhne, R.]]
[[Category: Kuhne, R.]]
Line 29: Line 28:
[[Category: breast cancer]]
[[Category: breast cancer]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:35:19 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:20:26 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA